Immune-mediated hemolytic anemia (IMHA) is a condition in which the body's immune system attacks its own red blood cells, leading to a decrease in red blood cells and a decrease in the oxygen-carrying capacity of the blood. Diagnosis of IMHA can be difficult and time consuming, but it is essential in order to ensure proper treatment and management of the condition.
Physical Examination
The first step in diagnosing immune-mediated hemolytic anemia is to perform a physical examination. During the exam, a healthcare professional will look for signs and symptoms of anemia, such as pale skin, jaundice, and fatigue. In addition, the healthcare provider may check the patient's blood pressure, heart rate, and temperature.
Laboratory Tests
Another important step in diagnosing IMHA is performing laboratory tests. These tests can help to confirm the presence of anemia and can also reveal additional information about the condition, such as the type and cause of anemia. Common laboratory tests used to diagnose IMHA include complete blood count (CBC), reticulocyte count, direct antibody test, and indirect antibody test.
Imaging Tests
In some cases, imaging tests may also be used to diagnose IMHA. Imaging tests such as ultrasound, CT scan, and MRI can be used to evaluate the size and shape of the spleen, which can be enlarged due to IMHA.
Bone Marrow Biopsy
In some cases, a bone marrow biopsy may be performed to make a definitive diagnosis of IMHA. During the biopsy, a small piece of bone marrow is removed and examined under a microscope for signs of anemia.
Conclusion
Diagnosis of immune-mediated hemolytic anemia can be difficult and time consuming, but it is essential in order to ensure proper treatment and management of the condition. Physical examination, laboratory tests, imaging tests, and bone marrow biopsy can all be used to diagnose IMHA.